Evidence map›Paper›PMID 37111811›Full record

ArticlePlants (Basel, Switzerland)2023

Protective Effect of the Phycobiliproteins from

Oscar Guzmán-Gómez, Rosa Virginia García-Rodríguez, Salud Pérez-Gutierrez, Nora Lilia Rivero-Ramírez, Yuliana García-Martínez, Saudy Saret Pablo-Pérez, Ricardo Pérez-Pastén-Borja, José Melesio Cristóbal-Luna, Germán Chamorro-Cevallos

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Protective Effects of Phycobiliproteins fromPharmaceuticals (Basel, Switzerland) · 2025
    Article
  4. Article
  5. The therapeutic potential ofTurkish journal of biology = Turk biyoloji dergisi · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Oscar Guzmán-GómezDepartamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Av. Wilfrido Massieu 399, Mexico City C.P. 07738, Mexico.
Rosa Virginia García-RodríguezInstituto de Química Aplicada, Universidad Veracruzana, Luis Castelazo Ayala S/N Col. Industrial Ánimas, Xalapa C.P. 91190, Mexico.
Salud Pérez-GutierrezDepartamento de Sistemas Biológicos, Universidad Autónoma Metropolitana-Xochimilco, Calzada del Hueso 1100, Mexico City C.P. 04960, Mexico.
Nora Lilia Rivero-RamírezDepartamento de Morfología, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Prolongación de Carpio y Plan de Ayala s/n, Mexico City C.P. 11340, Mexico.
Yuliana García-MartínezDepartamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Av. Wilfrido Massieu 399, Mexico City C.P. 07738, Mexico.ORCID 0000-0002-9103-0154
Saudy Saret Pablo-PérezDepartamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Av. Wilfrido Massieu 399, Mexico City C.P. 07738, Mexico.ORCID 0000-0001-5745-6437
Ricardo Pérez-Pastén-BorjaDepartamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Av. Wilfrido Massieu 399, Mexico City C.P. 07738, Mexico.ORCID 0000-0003-1069-5558
José Melesio Cristóbal-LunaDepartamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Av. Wilfrido Massieu 399, Mexico City C.P. 07738, Mexico.ORCID 0000-0003-4765-5568
Germán Chamorro-CevallosDepartamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Av. Wilfrido Massieu 399, Mexico City C.P. 07738, Mexico.ORCID 0000-0002-8935-9831
Instituto Politécnico Nacional · MXUniversidad Autónoma Metropolitana · MXUniversidad Veracruzana · MX

Funding

Secretaría de Investigación y Posgrado del Instituto Politécnico 20195923
6 · The paper itself

Abstract

Gastric ulcers (GU) constitute a disease with a global prevalence ≈ 8.09 million. Of their causes, non-steroidal anti-inflammatory drugs (NSAIDs) such as indomethacin (IND) rank as the second most frequent etiologic agent. The pathogenic process of gastric lesions is given by the overproduction of oxidative stress, promotion of inflammatory processes, and inhibition of prostaglandin synthesis. Spirulina

Indexed as

antiulcerogenicindomethacinoxidative stressphycobiliproteinsspirulina (Arthrospira maxima)

Identifiers

PMID37111811
PMCPMC10146595
OpenAlexW4363676144

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.